APA
ITRM

American Portfolios Advisors’s Iterum Therapeutics ITRM Stock Holding History

American Portfolios Advisors’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$215 Hold
133
– – ﹤0.01% 3453
2022
Q2 		$400 Hold
133
– – ﹤0.01% 3412
2022
Q1 		$710 Hold
133
– – ﹤0.01% 3424
2021
Q4 		$784 Hold
133
– – ﹤0.01% 3356
2021
Q3 		$1.12K Hold
133
– – ﹤0.01% 3277
2021
Q2 		$4.62K Buy
+133
New +$2.88K ﹤0.01% 2851

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

American Portfolios Advisors's ITRM Position: Q3 2022 in Review

American Portfolios Advisors held its Iterum Therapeutics (ITRM) position steady in Q3 2022 at 133 shares worth $215. The position accounts for ﹤0.01% of the portfolio, ranked #3453.

American Portfolios Advisors first reported a position in ITRM in Q2 2021 and has held it in 6 quarters since. The position peaked at $4.62K in Q2 2021. 25 funds tracked by Wall St. Rank hold ITRM as of Q3 2022.

  • American Portfolios Advisors held 133 shares of Iterum Therapeutics worth $215 as of Q3 2022.
  • American Portfolios Advisors left its Iterum Therapeutics share count unchanged in Q3 2022.
  • Iterum Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3453 holding.
  • American Portfolios Advisors first reported a position in Iterum Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Iterum Therapeutics position peaked at $4.62K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.